Novartis AG (NVS) stock analysis

In our weekly check, Novartis AG is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 4, red flags: 1.

About Novartis AG

Novartis AG is a Healthcare company (Drug Manufacturers - General) based in Switzerland, listed on NYSE as NVS.

What our checks show for NVS

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-03

Similar companies

AZN · MRK · AMGN · GILD · NVO · ABBV

Questions

What grade does Novartis AG (NVS) have?

In our weekly check, Novartis AG is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 4, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of NVS stock?

This week's biggest flags for Novartis AG: Margins falling, High debt, Dividend stretched. In total 5 of 25 checks show a warning or a red flag.

What does Novartis AG do?

Novartis AG is a Healthcare company (Drug Manufacturers - General) based in Switzerland, listed on NYSE as NVS.

When does Novartis AG report earnings next?

The next earnings report is expected on 2027-02-03. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis